HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma

Human T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus, is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell leukemia–lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 proteins,...

Full description

Bibliographic Details
Main Authors: Makoto Yamagishi, Dai Fujikawa, Toshiki Watanabe, Kaoru Uchimaru
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.01686/full
_version_ 1798044801176698880
author Makoto Yamagishi
Dai Fujikawa
Toshiki Watanabe
Kaoru Uchimaru
author_facet Makoto Yamagishi
Dai Fujikawa
Toshiki Watanabe
Kaoru Uchimaru
author_sort Makoto Yamagishi
collection DOAJ
description Human T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus, is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell leukemia–lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 proteins, including Tax and HBZ, have been shown to have critical roles in HTLV-1 pathogenicity, yet the underlying mechanisms of HTLV-1-driven leukemogenesis are unclear. The frequent disruption of genetic and epigenetic gene regulation in various types of malignancy, including ATL, is evident. In this review, we illustrate a focused range of topics about the establishment of HTLV-1 memory: (1) genetic lesion in the Tax interactome pathway, (2) gene regulatory loop/switch, (3) disordered chromatin regulation, (4) epigenetic lock by the modulation of epigenetic factors, (5) the loss of gene fine-tuner microRNA, and (6) the alteration of chromatin regulation by HTLV-1 integration. We discuss the persistent influence of Tax-dependent epigenetic changes even after the disappearance of HTLV-1 gene expression due to the viral escape from the immune system, which is a remaining challenge in HTLV-1 research. The summarized evidence and conceptualized description may provide a better understanding of HTLV-1-mediated cellular transformation and the potential therapeutic strategies to combat HTLV-1-associated diseases.
first_indexed 2024-04-11T23:10:09Z
format Article
id doaj.art-c4063224d4164712a050b871ae287af2
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-11T23:10:09Z
publishDate 2018-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-c4063224d4164712a050b871ae287af22022-12-22T03:57:53ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-07-01910.3389/fmicb.2018.01686384575HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–LymphomaMakoto Yamagishi0Dai Fujikawa1Toshiki Watanabe2Kaoru Uchimaru3Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanThe Institute of Medical Science, The University of Tokyo, Tokyo, JapanDepartment of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JapanHuman T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus, is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell leukemia–lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 proteins, including Tax and HBZ, have been shown to have critical roles in HTLV-1 pathogenicity, yet the underlying mechanisms of HTLV-1-driven leukemogenesis are unclear. The frequent disruption of genetic and epigenetic gene regulation in various types of malignancy, including ATL, is evident. In this review, we illustrate a focused range of topics about the establishment of HTLV-1 memory: (1) genetic lesion in the Tax interactome pathway, (2) gene regulatory loop/switch, (3) disordered chromatin regulation, (4) epigenetic lock by the modulation of epigenetic factors, (5) the loss of gene fine-tuner microRNA, and (6) the alteration of chromatin regulation by HTLV-1 integration. We discuss the persistent influence of Tax-dependent epigenetic changes even after the disappearance of HTLV-1 gene expression due to the viral escape from the immune system, which is a remaining challenge in HTLV-1 research. The summarized evidence and conceptualized description may provide a better understanding of HTLV-1-mediated cellular transformation and the potential therapeutic strategies to combat HTLV-1-associated diseases.https://www.frontiersin.org/article/10.3389/fmicb.2018.01686/fullHTLV-1ATLLepigeneticsEZH2gene expressiongene mutations
spellingShingle Makoto Yamagishi
Dai Fujikawa
Toshiki Watanabe
Kaoru Uchimaru
HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
Frontiers in Microbiology
HTLV-1
ATLL
epigenetics
EZH2
gene expression
gene mutations
title HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
title_full HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
title_fullStr HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
title_full_unstemmed HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
title_short HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
title_sort htlv 1 mediated epigenetic pathway to adult t cell leukemia lymphoma
topic HTLV-1
ATLL
epigenetics
EZH2
gene expression
gene mutations
url https://www.frontiersin.org/article/10.3389/fmicb.2018.01686/full
work_keys_str_mv AT makotoyamagishi htlv1mediatedepigeneticpathwaytoadulttcellleukemialymphoma
AT daifujikawa htlv1mediatedepigeneticpathwaytoadulttcellleukemialymphoma
AT toshikiwatanabe htlv1mediatedepigeneticpathwaytoadulttcellleukemialymphoma
AT kaoruuchimaru htlv1mediatedepigeneticpathwaytoadulttcellleukemialymphoma